Arthritis Clinical Trials

Find Arthritis Clinical Trials Near You

Comparison of Interscalene Brachial Plexus Block Versus the Combination of Suprascapular and Infraclavicular Brachial Plexus Block for Shoulder Surgery: A Randomized Controlled Trial With Diaphragmatic Function Assessment

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study will compare two regional anesthesia techniques for shoulder surgery and evaluate their effects on diaphragmatic function. The standard regional anesthesia technique for shoulder surgery is the interscalene brachial plexus block (ISB), which provides effective analgesia but is frequently associated with ipsilateral hemidiaphragmatic paresis due to phrenic nerve involvement. An alternative diaphragm-sparing strategy is the combination of a suprascapular nerve block (SSNB) and an infraclavicular brachial plexus block (ICB), which may reduce the risk of diaphragmatic dysfunction while maintaining effective analgesia for shoulder surgery. All participants will receive ultrasound-guided regional anesthesia prior to surgery and will be randomly assigned to one of two groups: Group 1: Interscalene brachial plexus block Group 2: Suprascapular nerve block combined with infraclavicular brachial plexus block The primary aim of this study is to determine whether the diaphragm-sparing technique reduces the incidence of hemidiaphragmatic paresis while providing analgesia comparable to the standard interscalene block. Diaphragmatic movement will be assessed using ultrasound before and after block placement. Secondary outcomes include postoperative pain intensity, opioid consumption, pulmonary function parameters, and block-related complications.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Maximum Age: 100
Healthy Volunteers: f
View:

• Age ≥ 65 years

• Elective shoulder surgery

• ASA I-III

• Planned use of regional anesthesia

• Signed written informed consent

Locations
Other Locations
Poland
Poznan University of Medical Sciences
RECRUITING
Poznan
Contact Information
Primary
Malgorzata Reysner, MD PhD
mreysner@ump.edu.pl
+48618738313
Time Frame
Start Date: 2025-12-10
Estimated Completion Date: 2027-01-31
Participants
Target number of participants: 70
Treatments
Active_comparator: Interscalene Block (ISB)
Participants will receive a single-shot ultrasound-guided interscalene block using 20 mL of 0.2% ropivacaine.
Active_comparator: Infraclavicular Block (ICB) + Suprascapular Nerve Block (SSNB)
Participants will receive two ultrasound-guided single-shot peripheral nerve blocks:~* Infraclavicular brachial plexus block: 15 mL of 0.2% ropivacaine~* Suprascapular nerve block: 5 mL of 0.2% ropivacaine~All blocks will be performed under ultrasound guidance.
Sponsors
Leads: Poznan University of Medical Sciences

This content was sourced from clinicaltrials.gov

Similar Clinical Trials